243 related articles for article (PubMed ID: 37053534)
1. Precision Medicine and Immunotherapy Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials.
Karasic TB; Eads JR; Goyal L
JCO Precis Oncol; 2023 Apr; 7():e2200573. PubMed ID: 37053534
[No Abstract] [Full Text] [Related]
2. Futibatinib: paving the way to personalized medicine in intrahepatic cholangiocarcinoma.
Khoury R; Chahine C; Ibrahim R; Khalife N; Saleh M; Saleh K
Future Oncol; 2023 Jun; 19(17):1161-1163. PubMed ID: 37293779
[No Abstract] [Full Text] [Related]
3. Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?
Braconi C; Roessler S; Kruk B; Lammert F; Krawczyk M; Andersen JB
Liver Int; 2019 May; 39 Suppl 1():32-42. PubMed ID: 30829432
[TBL] [Abstract][Full Text] [Related]
4. MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma.
Loeuillard E; Gores GJ; Ilyas SI
Cell Mol Gastroenterol Hepatol; 2021; 12(3):1153-1154. PubMed ID: 34242622
[No Abstract] [Full Text] [Related]
5. CD40-agonist: A new avenue for immunotherapy combinations in cholangiocarcinoma.
Casolino R; Braconi C
J Hepatol; 2021 May; 74(5):1021-1024. PubMed ID: 33612309
[No Abstract] [Full Text] [Related]
6. [The progress of chemotherapy for intrahepatic cholangiocarcinoma].
Ioka T; Katayama K
Nihon Shokakibyo Gakkai Zasshi; 2012 Nov; 109(11):1895-901. PubMed ID: 23132033
[No Abstract] [Full Text] [Related]
7. Novel precision therapies for cholangiocarcinoma: an overview of clinical trials.
Uson Junior PLS; Bearss J; Babiker HM; Borad MJ
Expert Opin Investig Drugs; 2023 Jan; 32(1):69-75. PubMed ID: 36714945
[TBL] [Abstract][Full Text] [Related]
8. [Systemic chemotherapy for cholangiocarcinoma].
Furuse J; Suzuki E; Hirokawa S; Kitamura H; Nagashima F
Nihon Shokakibyo Gakkai Zasshi; 2010 Jul; 107(7):1102-8. PubMed ID: 20616478
[No Abstract] [Full Text] [Related]
9. Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?
Roth GS; Neuzillet C; Sarabi M; Edeline J; Malka D; Lièvre A
Eur J Cancer; 2023 Jan; 179():1-14. PubMed ID: 36463640
[TBL] [Abstract][Full Text] [Related]
10. Precision approaches for cholangiocarcinoma: progress in clinical trials and beyond.
Uson Junior PLS; Borad MJ
Expert Opin Investig Drugs; 2022 Jan; 31(1):125-131. PubMed ID: 34904492
[TBL] [Abstract][Full Text] [Related]
11. [Photodynamic therapy for unresectable cholangiocarcinoma: does it really increase the survival time?].
Choi EK; Kim MH
Korean J Gastroenterol; 2005 Jun; 45(6):446; author reply 447. PubMed ID: 15973081
[No Abstract] [Full Text] [Related]
12. Photodynamic therapy of nenresectable cholangiocarcinoma.
Terruzzi V; Minoli G
Gastrointest Endosc; 1999 Nov; 50(5):727-8. PubMed ID: 10576983
[No Abstract] [Full Text] [Related]
13. FGFR inhibitor resistance in cholangiocarcinoma: current understanding and future directions.
Neureiter D; Ellinghaus P; Ocker M
Expert Opin Pharmacother; 2023; 24(17):1833-1837. PubMed ID: 37710362
[No Abstract] [Full Text] [Related]
14. What are the key challenges in the pharmacological management of cholangiocarcinoma?
Ledenko M; Patel T
Expert Opin Pharmacother; 2022 Apr; 23(5):531-533. PubMed ID: 34866539
[No Abstract] [Full Text] [Related]
15. Chemotherapy impregnated plastic biliary endoprostheses: one small step for man(agement) of cholangiocarcinoma.
Baron TH
Hepatology; 2000 Nov; 32(5):1170-1. PubMed ID: 11050071
[No Abstract] [Full Text] [Related]
16. Systemic Treatment for Cholangiocarcinoma.
Sookprasert A; Wirasorn K; Chindaprasirt J; Watcharenwong P; Sanlung T; Putraveephong S
Recent Results Cancer Res; 2023; 219():223-244. PubMed ID: 37660335
[TBL] [Abstract][Full Text] [Related]
17. Biliary photodynamic therapy alternative delivery technique.
Burdick JS; Magee D; Miller G; Wright KB
Endoscopy; 2000 Oct; 32(10):S63. PubMed ID: 11068847
[No Abstract] [Full Text] [Related]
18. [Ivosidenib in the treatment of patients with cholangiocarcinoma with an IDH1 R132 mutation who were previously treated by at least one prior line of systemic therapy].
Rabehi T; Quesada S
Bull Cancer; 2023 Dec; 110(12):1230-1231. PubMed ID: 37704495
[No Abstract] [Full Text] [Related]
19. Photodynamic therapy of cholangiocarcinoma cancer.
Ortner MA
Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):481-6. PubMed ID: 10899258
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint inhibitors in cholangiocarcinoma.
Beri N
Immunotherapy; 2023 May; 15(7):541-551. PubMed ID: 37096964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
